{"id":"W3120912770","doi":"10.1093/ofid/ofaa439.1221","title":"1035. Patient-Reported Outcomes on Long-Acting Cabotegravir + Rilpivirine as Maintenance Therapy: FLAIR 96-Week Results","year":2020,"lang":"en","type":"article","venue":"Open Forum Infectious Diseases","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"GlaxoSmithKline (Canada); University Health Network","funders":"","keywords":"Rilpivirine; Medicine; Abacavir; Dolutegravir; Randomized controlled trial; Human immunodeficiency virus (HIV); Internal medicine; Lamivudine; Antiretroviral therapy; Viral load; Family medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001044252,0.0004850199,0.0007115469,0.0001151256,0.0003763772,0.0001815013,0.0002213954,0.0000871771,0.0004110896],"category_scores_gemma":[0.0007926214,0.0003504525,0.0002795417,0.0004186999,0.00007624406,0.0002934288,0.0002217631,0.0002364618,0.0006529847],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002174968,"about_ca_system_score_gemma":0.0003352581,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004286614,"about_ca_topic_score_gemma":0.0001327556,"domain_scores_codex":[0.9973875,0.0000821629,0.0006644254,0.0007728315,0.0004894189,0.00060371],"domain_scores_gemma":[0.9981765,0.0001715168,0.0003645307,0.0005375214,0.000159973,0.0005899895],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003650028,0.002444247,0.9007593,0.0000401284,0.001088728,0.001566713,0.0007935893,0.00002844796,0.00004405589,0.0002263718,0.03112171,0.05823664],"study_design_scores_gemma":[0.04088527,0.007943776,0.7083536,0.0007735456,0.0007773172,0.0002166247,0.001722453,0.000134587,0.00464835,0.000904765,0.2319785,0.001661288],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8815814,0.0002101264,0.00003331284,0.02903257,0.0003537916,0.002748821,0.0001354935,0.0004883381,0.08541618],"genre_scores_gemma":[0.9801137,0.0001336433,0.00008536153,0.006947671,0.00007131541,0.0002353342,0.0004093504,0.00007864429,0.01192492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2008567,"threshold_uncertainty_score":0.9998947,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0276448731580631,"score_gpt":0.2947878649152534,"score_spread":0.2671429917571904,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}